Response from AHZ, page-40

I was saying that after this quarter of 15.5 Mil spend, the 2nd quarter will decline to less than 10 million, plus the company will be able to claim the R&D,  I expect the company on current growth to be cash positive in about 18 month.

we could sign the much awaited for TAVR deal and get some money that will help us through, if the SP goes to mid teens, the two big holders could convert the options to provide money for the company, there are around 20 Million worth of option waiting to be converted.

as for your advice (illegal as per the terms of HC for posting here) to sell or lose everything, the company has the support of the two big holders, hopefully with upcoming approvals, deals, a CR if needed won't happen at these rock bottom prices. from where I see things, the upside from here has a much greater chance than the downside. 

for argument sake, the company makes it to the stage of selling TAVR, how much would the MC be? 1 or 2 billion?  even with  over a billion shares that's still over a $1 per share. as usual this is NOT advice, DYOR.